|
Volumn 10, Issue 6, 2003, Pages 1811-1815
|
Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 15-3 ANTIGEN;
CADHERIN;
CARCINOEMBRYONIC ANTIGEN;
DNA;
PROTEIN P16INK4A;
SULFITE;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
BIOSYNTHESIS;
BREAST TUMOR;
CANCER INVASION;
DISEASE COURSE;
DNA METHYLATION;
FEMALE;
GENETICS;
HUMAN;
LYMPH NODE METASTASIS;
METASTASIS;
METHYLATION;
MIDDLE AGED;
PAGET NIPPLE DISEASE;
PATHOLOGY;
PHENOTYPE;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
TUMOR SUPPRESSOR GENE;
ADULT;
AGED;
APOPTOSIS;
BREAST NEOPLASMS;
CA-15-3 ANTIGEN;
CADHERINS;
CARCINOEMBRYONIC ANTIGEN;
CARCINOMA, DUCTAL, BREAST;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
DISEASE PROGRESSION;
DNA;
DNA METHYLATION;
FEMALE;
GENES, P16;
HUMANS;
LYMPHATIC METASTASIS;
METHYLATION;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
PHENOTYPE;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
SULFITES;
MLCS;
MLOWN;
|
EID: 2642578598
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.10.6.1811 Document Type: Article |
Times cited : (46)
|
References (0)
|